Elsevier

Neuroscience Letters

Volume 470, Issue 2, 12 February 2010, Pages 134-138
Neuroscience Letters

Dysfunction of dopamine release in the prefrontal cortex of dysbindin deficient sandy mice: An in vivo microdialysis study

https://doi.org/10.1016/j.neulet.2009.12.071Get rights and content

Abstract

Dystrobrevin binding protein-1 gene (DTNBP1), which encodes dysbindin protein, has been identified as a schizophrenia susceptibility gene. Dysbindin has been shown to contribute to the regulation of exocytosis and formation of synaptic vesicles. Although hypofrontality in schizophrenia underlies its pathophysiology, the molecular function of dysbindin in synaptic neurotransmission remains unclear. In the present study, we investigated depolarization-evoked dopamine (DA) and serotonin (5-HT) release in the prefrontal cortex (PFC) of sandy (sdy) mice, which have a deletion mutation in the gene encoding DTNBP1. In vivo microdialysis analysis revealed that extracellular DA levels in the PFC of wild-type mice were increased by 60 mM KCl stimulation, and the KCl-evoked DA release was significantly decreased in sdy mice compared with wild-type mice. Extracellular 5-HT levels in the PFC of wild-type mice were also increased by 60 mM KCl stimulation. The KCl-evoked 5-HT release did not differ between wild-type and sdy mice. There was no difference in basal levels of DA and 5-HT before the stimulation between two groups. Behavioral sensitization after repeated methamphetamine (METH) treatment was significantly reduced in sdy mice compared with wild-type mice whereas no difference was observed in METH-induced hyperlocomotion between two groups. These results suggest that dysbindin may have a role in the regulation of depolarization-evoked DA release in the PFC and in the development of behavioral sensitization induced by repeated METH treatment.

Section snippets

Conflict of interest

The authors declare that there are no conflicts of interest in the publication of the present work.

Acknowledgements

We thank Drs. N. Ogiso, Y. Ohya and K. Yano, Division for Research of Laboratory Animals, Nagoya University for their technical assistance. This study was supported in part by a Grant-in-Aid for Scientific Research (No. 19390062, 21790067) from the JSPS, Research on Risk of Chemical Substances, Health and Labor Science Grants supported by Ministry of Health, Labour and Welfare, the CREST from JST, the MEXT Global-COE Program, Academic Frontier Project for Private Universities; matching fund

References (34)

  • R.E. Straub et al.

    Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia

    Am. J. Hum. Genet.

    (2002)
  • K.E. Burdick et al.

    Genetic variation in DTNBP1 influences general cognitive ability

    Hum. Mol. Genet.

    (2006)
  • X.W. Chen et al.

    DTNBP1, a schizophrenia susceptibility gene, affects kinetics of transmitter release

    J. Cell Biol.

    (2008)
  • K.L. Davis et al.

    Dopamine in schizophrenia: a review and reconceptualization

    Am. J. Psychiatry

    (1991)
  • A.H. Fanous et al.

    Relationship between a high-risk haplotype in the DTNBP1 (dysbindin) gene and clinical features of schizophrenia

    Am. J. Psychiatry

    (2005)
  • C.A. Ghiani, M. Starcevic, I.A. Rodriguez-Fernandez, R. Nazarian, V.T. Cheli, L.N. Chan, J.S. Malvar, J. de Vellis, C....
  • J.S. Goodwin et al.

    Amphetamine and methamphetamine differentially affect dopamine transporters in vitro and in vivo

    J. Biol. Chem.

    (2009)
  • Cited by (39)

    • The influence of aripiprazole and olanzapine on neurotransmitters level in frontal cortex of prenatally stressed rats

      2016, Environmental Toxicology and Pharmacology
      Citation Excerpt :

      Schizophrenia is a severe mental disease of complex aetiopathogenesis and it often requires prolonged pharmacotherapy (Konradi and Heckers, 2003). As the prevalence of schizophrenia in the global population is high (about 1%) (Nagai et al., 2010), studies aimed at finding the causes of this disorder are an important aspect of medical development in the 21st century. Animal models of schizophrenia (Ratajczak et al., 2013a) that enable the identification of disease symptoms observed in the clinical presentation are one of the basic tools used in experimental studies.

    • Schizophrenia susceptibility gene product dysbindin-1 regulates the homeostasis of cyclin D1

      2016, Biochimica et Biophysica Acta - Molecular Basis of Disease
    View all citing articles on Scopus
    1

    Contributed equally to the work.

    View full text